Eurospital, an Italian IVD Company, focuses its activities on specific diagnostic sectors such as diagnosis of Coeliac Disease, IBD, detection of genetic predisposition to Coeliac, Type 1 Diabetes and Lactose Intolerance.
Actively present worldwide, Eurospital’s aim is to provide Paediatricians, Gastroenterologists and Laboratory Immunologists with highly innovative diagnostic tests such as Calprest family products, Eu-tTG, XeliGen, DiabeGen and LactoGen.